Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance
Reference number: TA161
Published: 27 October 2008
Last updated: 07 February 2018

Osteoporosis - secondary prevention including strontium ranelate: final matrix of Consultees and Commentators for the reconsideration of strontium ranelate

Osteoporosis - secondary prevention including strontium ranelate: final matrix of Consultees and Commentators for the reconsideration of strontium ranelate

Osteoporosis - secondary prevention including strontium ranelate: final matrix of Consultees and Commentators for the reconsideration of strontium ranelate
08 December 2010
(35.22 Kb 10 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 06 December 2010